Adverse Events Reporting System Needs Immediate Upgrade – FDA Consultant
This article was originally published in The Tan Sheet
Executive Summary
FDA should resume an abandoned plan for software acquisition and "immediately" begin the process of upgrading Center for Drug Evaluation and Research's Adverse Events Reporting System, a consultant hired by the agency recommends in a report that is highly critical of the center's efforts to create a second-generation AERS